Abstract Objectives: Because impaired renal function is detrimental for the conversion of calcidiol to calcitriol (D-hormone) and since D-hormone analogues have been shown to decrease the risk of falls, we investigated whether creatinine clearance (CrCl) is associated with the number of fallers and falls in elderly men and women. Methods: Within a randomized controlled study, we observed for 36 weeks 186 placebo-treated community-dwelling elderly men and women over 70, in an attempt to determine the influence of baseline CrCl on calcitropic hormone serum levels, as well as the influence of baseline CrCl on the number of fallers and falls over time. With the help of questionnaires, we regularly assessed fall incidence and frequency. The risk of falls and the risk of becoming a faller were assessed in multivariate-controlled logistic regression models according to a cutoff value of the CrCl set at 65 ml/min. Results: At baseline, serum levels of 1.25(OH) 2 D 3 and iPTH were, in multivariate-controlled analyses, significantly associated with CrCl (p<0.0001, p=0.001, respectively), whereas serum levels of 25(OH)D 3 were not associated with CrCl. Below a CrCl of 65 ml/min, 1.25(OH) 2 D 3 serum levels steadily declined. We therefore chose a CrCl of 65 ml/min as cutoff for further analyses. During the 36 weeks of observation, elderly people with a CrCl of <65 ml/min had, in multivariate controlled analyses, compared with elderly with a CrCl of ‡65 ml/min, a significantly higher incidence of number of fallers (25/70 vs 21/116; OR=4.01; 95% CI, 1.48-10.98; p=0.006), and a significantly higher incidence of falls (28/70 vs 23/ 116; OR=3.68; 95% CI, 1.38-9.82; p=0.009). Conclusions: For the first time we showed that in a communitydwelling population of elderly men and women, a CrCl of less than 65 ml/min is a significant and independent risk factor for fallers and falls.
Introduction
The risk of falling increases with aging. In elderly men and women, falls are, independent of the increased incidence of fall-related fractures [1, 2] , associated with loss of independence [3] , deterioration of quality life, and increased mortality [4] . Several studies have investigated the risk factors for falls in the elderly [5, 6, 7] . Among others, vitamin D deficiency and/or low D-hormone (calcitriol/1,25(OH) 2 D 3 ), associated with a decrease of muscle strength [8, 9, 10, 11] , decreased balance [8, 12, 13] , and loss of functional mobility [13, 14] , are more and more recognized to be important risk factors for falls in the elderly. Several recently published studies have shown that supplementation of vitamin D in vitamin D-deficient institutionalized women [15] and treatment with either calcitriol in osteopenic vitamin D-replete women [16] or alfacalcidol, a D-hormone prodrug, in a population of community-dwelling elderly non-vitamin D-deficient men and women [17] can significantly reduce frequency of falls [15, 16, 17] and number of fallers [17] .
The conversion of calcidiol (25(OH)D 3 ) to the metabolically most active form of vitamin D, the D-hormone (calcitriol/1.25(OH) 2 D 3 ), is highly dependent on the creatinine clearance [18, 19] . It is hypothesized that below a creatinine clearance of 60 ml/min [20] or 50 ml/ min [21] , the renal conversion of 25(OH)D 3 to 1.25(OH) 2 D 3 becomes insufficient [20, 21] . Several studies [8, 9, 22] suggest that even a slight decrease in 1.25(OH) 2 D 3 and a corresponding slight increase in iPTH serum levels, observed when creatinine clearance (CrCl) decreases to 60-80 ml/min [23] , is associated with subclinical myopathy and balance trouble. It is nowadays accepted that the related increased occurrence of falling, together with increased skeletal fragility, has a larger effect on age-related increased frequency of fractures than bone mass alone [22, 24] . According to the currently published updated K/DOQL (Kidney disease outcomes quality initiative guidelines by the US Kidney Foundation) [25] , a slight decrease of the CrCl is associated with a decrease in bone mineral density [26] , and since a CrCl below 60 ml/min increases significantly the risk of fractures, the guidelines suggest an intensive control of patients with decreased creatinine clearance [25, 26] .
Aging is associated with a deterioration of renal function, easily measurable as deterioration of the creatinine clearance, and several studies suggest that a significant number of elderly people, even with normal vitamin D serum levels (>12 ng/ml), may suffer from a deficiency of 1.25(OH) 2 D 3 [27, 28, 29] , due to the age-related impaired renal function and the consecutively decreased activity of the renal 1a-hydroxylase [21, 30] .
Since aging is associated with a decreasing creatinine clearance and consequently with decreased serum levels of 1.25(OH) 2 D 3 and since low 1.25(OH) 2 D 3 serum levels have been associated with risk of falls, we investigated whether creatinine clearance is a risk factor for falls.
Subjects and methods

Participants
This investigation was conducted as post hoc subanalysis in the framework of the Swiss Aims Study [17] . The Aims study was a large double-blind placebo-controlled randomized study to assess the influence of alfacalcidol (1-alpha-dihydroxy-cholecalcitriol, Bondiol; GRY Pharma, Germany), a 1.25(OH) 2 D 3 prodrug, on frequency of fallers and falls in community-dwelling elderly men and women, 70 years old and older. The follow-up was 36 weeks. The subjects of this investigation were the 186 participants randomized to placebo, comprising 90 men and 96 women [17] . All subjects underwent a medical examination and biochemical tests, and answered a food frequency questionnaire. Falls were assessed every 12 weeks after the baseline visit for a total of 36 weeks. Details of assessment of falls were described previously [17] . The protocol of this study was approved by the Ethical Review Board of the University of Basel and all participants provided written informed consent. The Data, Safety and Monitoring Board established by GWD Consult Germany (Safety and Monitoring Board, GWD Consult, Research Contract, Postfach 1210, 63152, Mu¨lheim/Main, Germany) reviewed the conduct of the study.
Methods
The dietary calcium and vitamin D intake was estimated by using a food frequency questionnaire, which also produced information on some demographic, lifestyle, and nutritional parameters [17] . Calcium was not supplied, none of the participants were receiving physical therapy or training programs at study entry, and no attempt was made to alter subjects' diets or physical activity during the study. Each subject was asked to keep a diary on fall incidence and to inform the study center by a telephone call within 48 h. At each study-site visit, data on fall incidence were reassessed (date, time, circumstances, injuries) by trained study nurses using an interview-administered, not validated, questionnaire. Falls were defined as ''unintentionally coming to rest on the ground, floor, or other lower level.'' With the permission of the participants all case reports of fall incidences were collected from the house physician or hospitals. In all subjects, blood samples were drawn for measurement of serum calcium, phosphate, creatinine, 25(OH)D 3, 1.25(OH) 2 D 3 , and iPTH. Serum levels of 25(OH)D 3 , 1.25(OH) 2 D 3 , and iPTH were measured by radioimmunoassay (Nichols): intra-assay variation was 5.1%, 5.0%, and 1.8; interassay variation was 7.9%, 10.8%, and 5.6%. All samples were immediately frozen at -80°C and analyzed by the same person in one batch. Normal ranges for adults were for iPTH <65 pg/ml, for 25(OH)D 3 12-124 ng/ml, and for 1.25(OH) 2 D 3 30-76 pmol/l. Creatinine clearance was calculated with the widely accepted formula from Cockroft et al., adjusted for gender [31] .
The statistical analyses were conducted using the SAS statistical software package, version 8.2, by the SAS Institute, Cary, NC, USA, licensed to the University of Basel, Switzerland. Comparisons of means were performed by multivariate-adjusted analyses of variance [32] . Since iPTH, 25(OH)D 3 , and 1.25(OH) 2 D 3 distributions were markedly skewed, logarithmic transformations of these variances were performed prior to analyses. The relationship between 1.25(OH) 2 D 3 and creatinine clearance was studied by multivariate-adjusted linear regression analyses. The determination of the appropriate cutoff point for the CrCl to be used for further analyses was determined using a receiver operating characteristic (ROC) curve [33] . Five percent significance level was maintained throughout these analyses, and all tests were two-sided.
Results
General
The mean age of the slightly overweight (mean BMI 26.7 ± 4.1 kg/m 2 ) participants was 75 years (75.0 ± 4.1) ( Table 1) . Mean laboratory values for iPTH, 25(OH)D 3 , 1.25(OH) 2 D 3 , and albumin serum levels were within the normal range, the mean creatinine clearance was slightly reduced (78.0 ± 20.3 ml/min) ( Table 1) .
Associations between creatinine clearance and calcitropic hormones, calcium and phosphate serum levels Serum levels of 25(OH)D 3 were not associated with creatinine clearance (p=0.62) (Fig. 1 ). Serum levels of 1.25(OH) 2 D 3 were significantly associated with creatinine clearance (p<0.001) (Fig. 2) . In the ROC analysis of the association between 1.25(OH) 2 D 3 and the creatinine clearance, the cutoff value for the creatinine clearance came out to be at 65 ml/min. Below a creatinine clearance of 65 ml/min, 1.25(OH) 2 D 3 serum levels steadily declined (Fig. 2) , and participants with a creatinine clearance of less than 65 ml/min had significantly lower mean 1.25(OH) 2 D 3 serum levels than participants with a creatinine clearance above 65 ml/ min (p=0.001) ( Table 2) . We therefore chose a creatinine clearance of 65 ml/min as a cutoff level for our further analyses and participants were accordingly classified in two groups (creatinine clearance <65 ml/ min vs ‡65 ml/min). In the group with a creatinine clearance of <65 ml/min, 7% had a creatinine clearance of <40 ml/min. For the other controlled variables, we found no significant differences between groups ( Table 2) .
Association between creatinine clearance and number of fallers and number of falls The multivariate analyses included predictors which have been previously shown to be associated with increased risk of falling or variables which were significantly different between participants with a creatinine clearance ‡65 ml/min and those with a creatinine clearance of <65 ml/min. These variables were (pg/ml) serum levels over time, total number of medications (N), use of phenprocoumon, estrogen, and diuretics, coffee intake, and intake of multivitamins. Number of comorbidities was assessed with the Charlson comorbidity index and was also included as a control variable in the analyses. During the 36 weeks of observation, the elderly community-dwelling men and women with a creatinine clearance of <65 ml/min had, in multivariate-controlled analyses, compared with the participants with a creatinine clearance of ‡65 ml/min, a significantly higher incidence of number of fallers (25 out of 70 vs 21 out of 116; OR=4.01; 95% CI, 1.48-10.89; p=0.006) and a significantly higher incidence of falls (28 falls in 70 elderly vs 23 falls in 116 elderly; OR=3.68; 95% CI, 1.38-9.82; p=0.009) ( Table 3) .
Discussion
We observed a significant relationship between creatinine clearance (CrCl) and 1.25(OH) 2 D 3 serum levels. We found no association between CrCl and 25(OH)D 3 serum levels. In our population, a creatinine clearance of less than 65 ml/min (low creatinine clearance) was associated with declining 1.25(OH) 2 D 3 serum levels. A creatinine clearance of less than 65 ml/min is considered a modest impairment of kidney function. Whereas, participants with a low creatinine clearance had significantly lower mean 1.25(OH) 2 D 3 serum levels than participants with a creatinine clearance of ‡65 ml/min, mean serum levels of 25(OH)D 3 and iPTH were not significantly different between groups. Other authors found similar relationships between 1.25(OH) 2 D 3 and creatinine clearance [20, 21] . Francis et al. observed in women with normal calcidiol serum levels, low 1.25(OH) 2 D 3 serum levels (defined as <31 pg/ml) with a creatinine clearance below 50 ml/min [21] .
Deficiency values for vitamin D, and accordingly low values for 1.25(OH) 2 D 3 (D-hormone/calcitriol), were established based on the concept of the classic deficiency diseases. However, functional parameters that have been related to vitamin D and 1.25(OH) 2 D 3 decline at serum levels which are above the defined deficiency levels. Serum concentrations of 1.25(OH) 2 D 3 , which are significantly above the lowest defined normal value of 1.25(OH) 2 D 3 , respectively associated increases in iPTH serum levels, have been shown to have a negative impact on muscle strength and functional mobility [8, 9] and have been related to myopathy [9, 10, 11, 28, 34] . Serum levels of 1.25(OH) 2 D 3 have been associated with decreased muscle strength, lower endurance [8, 9, 10, 11, 12] , reduced functional mobility [13, 14] , and atrophy of fast-twitch muscle fibers [35] . Also, 1.25(OH) 2 D 3 is an effective treatment of the iPTH-related decrease of energy metabolism in skeletal muscle and proteolysis of muscle proteins [36, 37, 38] . Low 1.25(OH) 2 D 3 serum Fig. 2 Association between 1.25(OH) 2 D 3 (D-hormone) serum levels and creatinine clearance levels and related high normal iPTH levels have been associated with subclinical myopathy [10, 11, 39] . In one study, 1.25(OH) 2 D 3 has been shown to reduce the release of interleukin 6 (IL-6) from human blood monocytes, while 25(OH)D 3 was ineffective [40] . In another study, 1.25(OH) 2 D 3 increased insulin-like growth factor (IGF-I) in vivo [41] . Both factors-increasing IL-6 and decreasing IGF-I-are synergistic risk factors for functional disability [42] . The results from these studies [9, 10, 11, 28, 29, 30, 40, 41, 42] suggest that 1.25(OH) 2 D 3 is an independent risk factor for decreased muscle strength [12, 13] , reduced functional mobility [14] , and for falls [8, 16, 17, 43] , suggesting a direct involvement of 1.25(OH) 2 D 3 in the causal pathogenic pathway of decreased muscle strength-related falls [39] .
Specific receptors for 1.25(OH) 2 D 3 have been found in muscle tissue [44, 45] . Sorenson et al. showed that fast-twitch type II muscle fibers atrophy in the absence of 1.25(OH) 2 D 3 and reappear by treatment with alfacalcidol [35] . Analogues of 1.25(OH) 2 D 3 (D-hormone) have been shown to have an effect on muscle power and neuromuscular coordination [39, 43, 46, 47, 48] . The results of these studies, as well as our finding that the only significant difference in participants with a low creatinine clearance compared with participants with a creatinine clearance of ‡ 65 ml/min was the difference in mean 1.25(OH) 2 D 3 serum levels, suggest that the main vitamin D-dependent effect on muscle and locomotion comes from the most active form of vitamin D, the 1.25(OH) 2 D 3 (D-hormone). We therefore conclude that our observed approximately four times increased risk of falls observed in participants with a low creatinine clearance is due to a creatinine clearance-dependent decrease in 1.25(OH) 2 D 3 serum levels. A creatinine clearance below 65 ml/min can be considered as a surrogate parameter for low 1.25(OH) 2 D 3 serum levels. Treatment options for patients should therefore clearly differentiate between the nutritive vitamin D deficiency and the metabolic low D-hormone syndrome.
Several risk assessment tools are proposed for the detection of elderly with an increased risk for falls and for preventive intervention. These tools are mostly used in fall assessment clinics because they are time consuming and need a trained risk assessment team. These risk assessment tools help to identify several risk factors for falls and offer the possibility of multifactorial intervention. While several studies have shown that multifactorial intervention may prevent falls, other studies have shown that multifactorial interventions are not appropriate for all elderly and that they fail in preventing falls [49, 50] . In general, the determination of the creatinine clearance is of great clinical utility in the identification of elderly with an increased risk for falls since its determination offers multiple advantages. Compared with the determination of 1.25(OH) 2 D 3 , the measurement of serum creatinine to calculate creatinine clearance is easy, cheap, and independent of seasonal or diurnal variations. In our study, elderly men and women with a creatinine clearance below 65 ml/min had, in multivariatecontrolled analyses, a fourfold increased risk to become fallers and a 3.7-fold increased risk for falls, during an observation time of 36 weeks. In a retrospective analysis of an observational, not-yet-published study in Germany on incidence of osteoporosis, falls, and creatinine clearance among 5,441 German osteoporotic women and men aged 60-92 years, based on our cutoff value of 65 ml/min, a low creatinine clearance was compared with a creatinine clearance of ‡65 ml/min also associated with an increased risk for falls and fractures (E. Schacht, Metabolic Bone Disease Unit. Universita¨tsklinik Balgrist, Zurich, Switzerland, personal communication). We are the first to show that a low creatinine clearance is associated with an increased risk of falls.
Our results have several limitations. The results come from post hoc analyses. The participants were Caucasian community-dwelling men and women over the age of 70, so our findings are not generalizable to a younger population, to the institutionalized elderly, or to men and women of other races. Since our analyses were done with participants who received placebo during 36 weeks, we can not rule out an influence in either direction of placebo on risk of falls. Assessment of risk factors for falls, as well as the large part of the incidence of falls, during the study was based only on the participant's own report. Finally we can not exclude uncontrolled confounding.
In conclusion, a low creatinine clearance of <65 ml/ min, as a surrogate parameter for low creatinine clearance-associated low 1.25(OH) 2 D 3 serum levels, is a significant, independent, and easily measurable risk factor for falls, associated with a fourfold increased risk to become a faller and a 3.7-fold increased risk to experience a fall.
